The Interface Blog is the best place to find detailed perspectives on autoimmune hepatitis. We publish the most up-to-date news, educational pieces, and stories about patients just like you.
The Autoimmune Hepatitis Association This past year, a few cases have been reported of AIH developing and possible AIH flares after SARS-CoV-2 vaccination. Recently,...
By Craig Lammert, M.D., AIHA Executive Director Over the past year, a few members of the Autoimmune Hepatitis Association (AIHA) have emailed us or shared in our...
By the Autoimmune Hepatitis Association As we have shared this past year, very rare cases of autoimmune-like liver injury after COVID-19 vaccine have been reported in...
By the Autoimmune Hepatitis Association The Omicron variant of SARS-CoV-2 is spreading quickly across the globe. Scientists are still sorting out its impact, but we...
By the Autoimmune Hepatitis Association New recommendations for booster vaccines have been issued in the US for those who received the Moderna and Johnson & Johnson...
By the Autoimmune Hepatitis Association Advisers to the Centers for Disease Control and Prevention (CDC) voted unanimously in favor of a third dose of Pfizer (age 12 or...
By the Autoimmune Hepatitis Association Researchers have published the first report of using a third dose of vaccine to 30 organ transplant patients with suboptimal...
By the Autoimmune Hepatitis Association In May, a follow-up study from researchers at John Hopkins showed how immunosuppressed patients respond after the second dose of...
By the Autoimmune Hepatitis Association The full impact of SARS-CoV-2 infection (the virus causing COVID-19) on autoimmune hepatitis (AIH) patients is still unknown....
New research is raising concerns about how well COVID-19 vaccines work for patients on immunosuppressants. AIHA Executive Director Craig Lammert, M.D., puts a new study...
The Johnson & Johnson vaccine is now available in some areas in the US, and many patients have questions about whether it's safe. We have answers! AIHA Executive...
By Erin AndersonAIHA Director of Programs and Advancement Getting an injection is the last thing most patients want to do. But COVID-19 and the isolation the pandemic...
By Craig Lammert, M.D.AIHA Executive Director Two of my three children tested positive for SARS-CoV-2 three weeks ago. We are all fine and everyone is now out of...
By the Autoimmune Hepatitis Association The American Association for the Study of Liver Diseases (AASLD) released their expert panel consensus on vaccines to prevent...
By the Autoimmune Hepatitis Association The arrival of new variants of the coronavirus in the US have some experts advising that now is the time to consider what type...
By Craig Lammert, M.D.AIHA Executive Director The first few days of 2021 gave me a different view of medicine than I am accustomed to. My institution asked me to...
By the Autoimmune Hepatitis Association Two SARS-Cov-2 vaccines were submitted to the FDA for emergency use authorization near the end of November 2020. Many believe...
An update from AIHA Executive Director Craig Lammert, M.D., about taking immunosuppressants during COVID-19.